Direct-to-consumer genetic testing the implications of the US FDA's first marketing authorization for BRCA mutation testing

JAMA - Journal of the American Medical Association

Volumn 319, Issue 23, 2018, Pages 2377-2378

  Gill, Jennifer ^a   Obley, Adam J ^b   Prasad, Vinay ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER PREVENTION; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL OUTCOME; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIRECT TO CONSUMER GENETIC TESTING; EMPOWERMENT; FAMILY HISTORY; FIRST MARKETING AUTHORIZATION; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; GENE TECHNOLOGY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH SERVICE; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MASTECTOMY; MEDICAL INFORMATION; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; SAFETY; SALIVATION; SENSITIVITY AND SPECIFICITY; TUBAL CANCER; TUMOR SUPPRESSOR GENE; UNITED STATES; BREAST TUMOR; ETHNOLOGY; FEMALE; GENETICS; GOVERNMENT REGULATION; LEGISLATION AND JURISPRUDENCE; MARKETING; MUTATION; PREDICTIVE VALUE; SCREENING TEST; UTILIZATION;

BREAST NEOPLASMS; DIRECT-TO-CONSUMER SCREENING AND TESTING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; GOVERNMENT REGULATION; HUMANS; MARKETING; MEDICAL OVERUSE; MUTATION; PREDICTIVE VALUE OF TESTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85049262875     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.5330     Document Type: Review

References (10)

1. US Food and Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports 3 mutations in the BRCA breast cancer genes. https://www.fda.gov/NewsEvents /Newsroom/PressAnnouncements/ucm599560 .htm. Accessed May 1, 2018.
2. Wojcicki A. A major milestone in consumer health empowerment. https://blog.23andme.com /health-traits/major-milestone-consumer-health -empowerment/. Accessed May 1, 2018.
3. Park A. You can now order an at-home genetic test for breast cancer: But should you?. http://time .com/5189939/genetic-testing-breast-cancer/. Accessed May 1, 2018.
4. Manchanda R, Loggenberg K, Sanderson S, et al. Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: A randomized controlled trial. J Natl Cancer Inst. 2014;107(1):379.
5. Moyer VA; US Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(4):271-281.
6. Jolie A. My medical choice. https://www.nytimes .com/2013/05/14/opinion/my-medical-choice.html. Accessed May 1, 2018.
7. Roberts MC, Dusetzina SB. The effect of a celebrity health disclosure on demand for health care: Trends in BRCA testing and subsequent health services use. J Community Genet. 2017;8(2):141-146.
8. Desai S, Jena AB. Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial. BMJ. 2016;355:i6357.
9. Mouchawar J, Hensley-Alford S, Laurion S, et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturallyoccurring experiment. Genet Med. 2005;7(3):191-197.
10. Lowery JT, Byers T, Axell L, Ku L, Jacobellis J. The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk. Genet Med. 2008;10(12):888-894.